Healthtech & Wellness VC Funds

Morpheus Ventures, founded in 2016 and based in Los Angeles, focuses on early-stage investments in cutting-edge technologies such as data analytics, machine learning, robotics, and SaaS. Their portfolio includes innovative companies like Rigetti Computing, Vicarious, and Starship Technologies. The firm has made significant exits including Rigetti Computing and Vicarious (acquired by Alphabet). Other notable investments include HouseCanary, a real estate data analytics company, SafetyCulture, a leading safety and quality inspection software, and Sidecar Health, a health insurance platform. The leadership team at Morpheus Ventures includes experienced investors like Damien Petty, who has a background in artificial intelligence, robotics, and quantum computing, and has led investments in companies like DeepMind (acquired by Google) and Skype (acquired by Microsoft). The team focuses on identifying and nurturing companies with the potential to disrupt their respective industries and drive significant advancements in technology.

Mosaic General Partnership (MGP) is a venture capital firm founded in 2021 and headquartered in San Francisco. The firm primarily focuses on early-stage investments in sectors like fintech, healthcare, and consumer technology. MGP is co-founded by a diverse team of industry leaders, including Andre Iguodala, Fatima Husain, Rudy Cline-Thomas, and Sam Landman, all of whom bring unique expertise in technology, sports, and culture. MGP stands out for its focus on investing in underrepresented founders and companies with the potential to create significant impact. The firm leverages its extensive network of founders, athletes, and industry influencers to accelerate the growth of its portfolio companies. MGP has made over 120 investments, including notable companies like Joya Health, Brex, and Stance, helping these startups scale through capital, mentorship, and strategic guidance. What makes MGP unique is its dedication to diversity and its hands-on approach to venture investing. The firm sees venture capital as a tool for driving large-scale social and economic change, making it a key player in the venture ecosystem. MGP operates across multiple U.S. cities, including San Francisco, New York, and Philadelphia, with a deep commitment to fostering innovation and inclusivity in tech.

Mosaic Ventures, established in 2014 and based in London, focuses on early-stage investments, primarily in Series A rounds, targeting transformative technology startups across Europe. Their portfolio includes notable investments such as Veriff, an AI-based identity verification software; Blockstream, a developer of blockchain-based platforms; and Illumio, which provides cloud workload security solutions. Mosaic Ventures is sector-agnostic, with investments spanning various industries including AI, blockchain, fintech, and enterprise software. They typically invest between $1M to $10M, emphasizing long-term partnerships and market research to support the growth of innovative companies. Key team members include co-founders Simon Levene and Toby Coppel, both of whom have extensive experience in Silicon Valley and Europe. The team also includes Benedict Evans as a venture partner, bringing deep insights from his time at Andreessen Horowitz. For startups, Mosaic Ventures values clear, innovative pitches that showcase strong market potential and technological advancements. They build their investment funnel through proactive scouting and a robust network, aiming to partner with entrepreneurs reimagining the future of technology.

Motivate Venture Capital (Motivate VC) is a forward-thinking seed-stage investment firm known for backing ambitious founders tackling significant problems with high-growth potential. The firm has invested in notable startups such as Aucto, a marketplace for industrial equipment, and Dyania Health, which leverages AI for clinical research. They primarily focus on sectors including fintech, AI, SaaS, and industrial automation. Geographically, Motivate VC is based in the United States with a strong presence in major innovation hubs like New York and Chicago. They are early-stage specialists, often being the first institutional money in with average check sizes ranging from $250K to $750K for pre-seed and $1.5M to $3M for seed investments. Motivate VC does not target specific ownership percentages but typically aims for 10-15% equity at the seed stage. Motivate's investment strategy is built on supporting founders with strong domain knowledge and providing them with not just capital, but also connections and strategic support. They value early signs of product-market fit and favor startups with unique competitive advantages. Founders are encouraged to approach them through their extensive network, emphasizing warm introductions from co-investors and entrepreneurs they trust. The team at Motivate VC includes experienced professionals like Jackson Bubala, who focuses on fintech and enterprise software investments, bringing a wealth of knowledge from his time at Manifold Group. The firm's culture is entrepreneurial, aiming to balance active support with allowing founders the space to lead their ventures effectively.

MTN Group is a leading telecommunications company based in Johannesburg, South Africa. The company has a strong presence across Africa and the Middle East, serving over 289 million subscribers. MTN Group's investment arm has made notable investments in sectors such as telecom infrastructure, renewable energy technology, and horizontal e-commerce. Key investments include companies like Fenix International, a renewable energy company acquired by ENGIE, and Jumia, a leading e-commerce platform in Africa. Another significant investment is in IHS Towers, one of the largest independent owners, operators, and developers of shared telecommunications infrastructure. MTN Group has committed substantial funds towards infrastructure projects to enhance its service delivery. For instance, it pledged $215 million for infrastructure investment in Benin over three years, focusing on building a state-of-the-art office for MTN Benin and expanding digital solutions across the region. Financially, MTN Group has reported strong performance with a 23.4% return on equity and a 10% increase in dividends to 330 cents per share. The group's strategic focus includes expanding its fintech ecosystem, investing in network infrastructure, and promoting digital inclusion across its markets.

Movens Capital is a Warsaw-based venture capital firm that primarily invests in early-stage and growth companies across Poland and Central Eastern Europe (CEE). Established in 2018, the firm manages two main funds: Movens Venture Capital, which focuses on seed and Series A investments in high-growth technology companies, and Movens Growth Equity, aimed at providing equity capital to scale up digital and consumer-focused small-to-medium enterprises (SMEs). Their investment range typically spans from €2 million to €6 million. Movens Capital specializes in sectors like fintech, SaaS, deep tech, marketplaces, medtech, and e-commerce support. They have a strong track record of supporting startups such as Vue Storefront, Sky Engine AI, and Doctor.One. These investments demonstrate their focus on innovative solutions with global scalability, especially those looking to expand into the U.S. and European markets. The firm is led by partners Artur Banach, Michał Olszewski, and Łukasz Pawłowski, who bring decades of entrepreneurial and investment expertise. They are known for their hands-on support in scaling businesses, providing not only capital but also strategic guidance through initiatives like the Movens Academy and Movens Advisory. These programs offer crucial assistance in areas like pricing strategy, HR, and international expansion to help portfolio companies achieve sustainable growth.

Moving Capital, now known as Karman Ventures, is a venture capital firm founded by Uber alumni to support startups with innovative solutions. The firm has made notable investments across various sectors, including aerospace, artificial intelligence, retail technology, and green technology. Noteworthy investments by Karman Ventures include Whisper Aero, a company focusing on aerospace and green technology; Luca, which specializes in AI-driven retail technology; and Regent, which develops electric vehicles for marine transportation. Other significant investments are in companies like Gigs, focusing on mobile applications, and Kasa Living, a hospitality tech company. Karman Ventures is based in Austin, Texas, and has a strong network of co-investors, including prominent firms like Y Combinator, Menlo Ventures, and LaunchTN. Their investment strategy typically involves supporting companies from seed to growth stages, emphasizing scalable and transformative technologies.

Moxxie Ventures is a venture capital firm founded in 2019 by Katie Jacobs Stanton, a former Twitter executive and co-founder of the #ANGELS investment collective. The firm is based in Mountain View, California, with a secondary office in Boulder, Colorado. Moxxie Ventures focuses on early-stage investments, particularly in consumer, enterprise, fintech, healthtech, and climate sectors. Moxxie Ventures recently closed its second fund at $85 million, a significant increase from its inaugural $25 million fund. The firm typically writes checks ranging from $250,000 to $500,000 and aims to make 10 to 12 investments per year, reserving half of the fund for follow-on investments. Notable investors backing Moxxie Ventures include Bain Capital Ventures, Bloomberg Beta, Foundry Group, and individual investors such as Marc Andreessen, Susan Wojcicki, and Jerry Yang. The firm prides itself on bringing a combination of capital, operating experience, and a strong network to its portfolio companies. Stanton and her team leverage their extensive backgrounds in product, engineering, marketing, and business development to support founders in scaling their businesses. Moxxie Ventures is committed to partnering with founders who are passionate about making life and work better through innovative solutions. Some of their notable investments include companies like Elpha, Carta, and Clubhouse. The firm continues to build on its mission to support founders with not just funding but also strategic guidance and connections to a broad network of industry experts and leaders.

MPM Capital, founded in 1997, is a leading venture capital firm based in Boston and San Francisco, specializing in biotechnology and life sciences investments. The firm has a robust portfolio, having invested in over 150 companies, including notable names like 23andMe, ReNAgade Therapeutics, and Argenx. MPM Capital's focus is on transforming innovative scientific discoveries into breakthrough medicines, particularly in oncology and other high-need therapeutic areas​. MPM Capital recently raised $850 million for its second Oncology Impact Fund, marking it as one of the largest biotech impact investment funds globally. This fund emphasizes investments in companies developing novel cancer therapies, reflecting MPM's deep commitment to addressing significant medical challenges. The firm's team includes seasoned professionals with extensive experience in research, drug development, and corporate strategy. Key team members like Dr. Luke Evnin and Dr. Ansbert Gadicke bring invaluable expertise to the firm, guiding its strategic investments and supporting portfolio companies through various growth stages​ .

MState Capital is a venture capital firm dedicated to early-stage investments in B2B SaaS companies. They focus on fostering technological advancements and supporting startups that aim to disrupt traditional business practices. Notable investments by MState Capital include companies such as HashiCorp, which went public in December 2021, and Affirm, which also completed its IPO in January 2021. Other significant investments include Monte Carlo, a data reliability platform, and Homebase, an all-in-one HR management tool for small businesses. MState Capital operates with a hands-on approach, providing strategic support and guidance to their portfolio companies. This includes assistance in building executive teams, refining business strategies, and facilitating connections with potential partners and customers. Their investment strategy emphasizes partnering with startups at the pre-seed and seed stages, and they often lead investment rounds, ensuring active involvement in the growth and development of their portfolio companies​. The firm is led by a team of experienced investors and entrepreneurs who bring a wealth of knowledge and industry insights to the table. Their commitment to long-term partnerships and founder alignment is a cornerstone of their investment philosophy, making them a valuable ally for startups looking to scale and succeed in competitive markets​.

Mubadala Capital’s Ventures platform stands out as a leading global investor, blending the strengths of Mubadala Investment Company with the agility of a venture capital firm. Focused on technology and healthcare sectors, Mubadala has made over 75 investments, including notable startups like Chroma Medicine, Recursion Pharmaceuticals, and Exscientia. Their strategy revolves around partnering with visionary founders to build enduring companies, leveraging Mubadala’s extensive resources and global scale. Geographically, Mubadala Ventures operates with a significant presence in technology hubs such as San Francisco, London, and Abu Dhabi, ensuring deep integration into the global innovation ecosystem. They emphasize Series A+ investments in the U.S. and Series B+ in Europe, providing substantial capital and strategic support to their portfolio companies. Mubadala's investment strategy is marked by a focus on capital preservation and downside protection, ensuring sustainable growth and returns. The fund typically invests in founder-led companies, with average check sizes tailored to the needs of each growth stage. They are known for their disciplined approach to evaluating opportunities, benefiting from Mubadala's broad network and sovereign backing. The team at Mubadala Ventures includes industry veterans like Ibrahim Ajami, Head of Ventures, and Alaa Halawa, Co-Head of US Ventures. Their expertise spans various sectors and geographies, further strengthening Mubadala’s investment acumen. Startups looking to engage with Mubadala are advised to highlight their alignment with Mubadala’s strategic focus and demonstrate robust business models that can benefit from Mubadala’s vast resources and network.

Mucker Capital, founded in 2012 and headquartered in Los Angeles, is a venture capital firm that invests in seed and early-stage startups across the United States, Canada, and beyond. With additional offices in Austin and Toronto, Mucker Capital focuses on internet-enabled software and services, aiming to support startups outside the traditional Silicon Valley ecosystem. The firm believes that great companies can be built anywhere and provides tactical help, networking opportunities, and a bridge to Silicon Valley resources. Notable portfolio companies include Honey, acquired by PayPal; Surf Air, which went public on NASDAQ; and ServiceTitan, a business management software for home service providers. Mucker Capital has also backed companies like The Black Tux, ServiceTitan, and BloomNation. MuckerLab, their pre-seed accelerator, is highly regarded and ranked second in the U.S. by the Seed Accelerator Rankings Project based on valuations, exits, fundraising, survival, and founder satisfaction. Mucker Capital's approach includes rolling up their sleeves to work alongside entrepreneurs on product development, marketing, sales, recruiting, and other critical areas to help startups succeed. The firm has launched multiple funds, including Mucker III, a $45 million seed-stage fund, and continues to support the growth and scaling of innovative startups.

Munich Re, founded in 1880, is one of the world's leading providers of reinsurance, primary insurance, and risk management solutions. Headquartered in Munich, Germany, the company operates globally, offering comprehensive risk assessment and financial protection across a wide range of sectors. Munich Re has consistently ranked at the top of the global reinsurance industry, thanks to its robust risk management practices, financial stability, and innovative approach to emerging risks. The company’s strategy, known as Ambition 2025, focuses on three core pillars: Scale, Shape, and Succeed. This strategy aims to enhance Munich Re's core business, develop new digital and innovative business models, and deliver added value to shareholders, clients, employees, and communities. The company is particularly focused on expanding its reinsurance operations, modernizing IT infrastructure, and pushing the boundaries of digital solutions, including cybersecurity and the Internet of Things (IoT). In terms of financial performance, Munich Re reported a consolidated result of €4.6 billion for 2023, with a solvency ratio of 267%, reflecting its financial strength and stability. The company is also committed to sustainability, setting ambitious goals to decarbonize its operations and investment portfolio, with the aim of achieving net-zero emissions by 2050. Munich Re’s global presence is supported by over 42,800 employees across more than 50 countries, making it a critical player in managing complex and extraordinary risks worldwide​.

Muse Capital is an early-stage venture capital fund based in Los Angeles, California, focused on investing in consumer-facing startups. Founded in 2016, the firm aims to bridge the gap between Silicon Valley, the entertainment industry, and the corporate sector, providing strategic capital and partnership-based business development. Muse Capital has a diverse portfolio that includes companies like CoFertility, Beekeeper's Naturals, Cloud Paper, and Firefly, all of which are pushing boundaries in telehealth, education, motherhood, gaming, and underserved markets. The firm is led by Assia Grazioli-Venier and Rachel Springate, who leverage their extensive networks in the entertainment and corporate worlds to support their portfolio companies. Muse Capital typically invests in seed-stage rounds, providing both financial backing and strategic guidance to help startups grow and succeed. Muse Capital is particularly known for its active involvement in the companies it invests in, offering tactical insights and connections to key industry players. This hands-on approach has made Muse a valuable partner for entrepreneurs looking to disrupt and innovate within the consumer sector. For startups looking to engage with Muse Capital, demonstrating a clear vision for consumer impact and leveraging the firm’s entertainment and corporate connections can be crucial.

Musa Ventures is a cutting-edge platform dedicated to improving the funding readiness of startups and small to medium businesses (SMBs). They leverage advanced analytics, artificial intelligence, and machine learning to deliver comprehensive venture health assessments. This holistic approach goes beyond financial metrics, providing founders with detailed insights into their ventures' strengths and areas needing improvement. The platform offers intelligent venture health dashboards that give real-time feedback and actionable recommendations. These dashboards are designed to help founders understand strategic gaps and enhance their appeal to potential funders. By offering objective feedback and insights from experienced advisors, Musa Ventures aims to make the fundraising process more transparent and accessible. Musa Ventures also employs proprietary assessment tools developed from over 30 years of global experience and research into ventures and SMBs. These tools analyze data from more than 20,000 ventures and involve input from over 600 funding firms, ensuring a robust and reliable evaluation process. In addition to assessments, Musa Ventures uses algorithmic matching to connect funding-ready ventures with suitable funders or partners. This approach helps streamline the funding process, making it easier for businesses to secure the right type of funding from the right sources. Musa Ventures thus plays a pivotal role in fostering a symbiotic relationship between startups and financial backers, ultimately contributing to healthier and more successful business ventures.

Mustard Seed VC, founded in 2015 by Henry Wigan and Alex Pitt, is a London-based venture capital firm focusing on impact investments. They back innovative businesses that tackle significant social and environmental challenges. Their investment philosophy emphasizes the "lock-step" approach, where the business model inherently benefits society, aligning with their goal of sustainable capitalism. Mustard Seed VC's portfolio includes notable investments such as What3Words, a geocoding system that improves location accuracy, and Winnow Solutions, which uses technology to reduce food waste. The firm has had successful exits, including Lifecake, a family photo-sharing app acquired by Canon. They typically invest in seed and growth stages, with investment sizes ranging from £100,000 to £500,000, and have the capacity to follow on into Series A rounds. Mustard Seed is committed to long-term partnerships, offering extensive support to their portfolio companies. Mustard Seed's impact-driven approach has attracted support from significant backers like Big Society Capital, enhancing their ability to drive capital towards socially impactful ventures. Their guiding principles include fortitude, persistence, humility, and audacity, which they believe are essential for building transformative businesses​.

MVM Partners, founded in 1997, is a global venture capital firm focused on high-growth healthcare investments. With offices in Boston and London, MVM invests broadly across sectors including medical technology, pharmaceuticals, diagnostics, digital health, and other healthcare-related fields. Their portfolio includes notable companies such as SkyCell, which developed patented temperature-control technology for safely transporting vaccines and biotech drugs, and Ossio, which created OSSIOfiber Intelligent Bone Regeneration Technology—a novel orthopedic fixation material that integrates into native bone and avoids the need for permanent metal implants. MVM also invested in MDxHealth, a company specializing in molecular diagnostics for urologic cancers, which enhances personalized cancer diagnosis and treatment. MVM's investment strategy emphasizes significant minority stakes in innovative companies, providing both financial support and strategic guidance to help these companies grow and scale. Their approach involves close collaboration with management teams to drive business development and market expansion. MVM's recent investments include companies like eXmoor Pharma, which focuses on cell and gene therapy services, and Nalu Medical, which develops minimally invasive solutions for chronic pain management. These investments reflect MVM's commitment to supporting advancements in medical technology and improving patient outcomes globally.

MVP Ventures is a venture capital firm that focuses on early-stage investments in highly technical, deep-technology innovations. Their approach is centered on partnering with founders at the earliest stages, particularly in software and hardware solutions that address significant problems across large markets. MVP has built an impressive portfolio that includes cutting-edge companies such as Dataminr, which uses AI to detect real-time digital patterns, and Luminous Computing, which is revolutionizing AI computing with photonic chips. MVP is known for its data-driven, systematic approach to deal sourcing, helping them uncover top opportunities in deep-tech sectors. Their investment strategy is built around making significant early-stage investments in startups that show potential for disruption in industries such as AI, robotics, and advanced materials. Their portfolio spans multiple sectors, including healthcare, construction tech, fintech, and space tech, with companies like Gecko Robotics, Mighty Buildings, and Loft Orbital leading the way. With a deep commitment to working alongside founders, MVP Ventures takes an active role in helping startups scale, often leading investment rounds and providing hands-on support. The firm is driven by a vision to back ambitious innovators and help them build transformative companies that address global challenges. MVP Ventures also places a strong emphasis on building durable, defensible businesses that can withstand market shifts, ensuring long-term growth and success.

Mystic Ventures, founded in 2021 and based in Los Angeles, is a venture capital firm focused on the rapidly growing psychedelic medicine and mental health sector. The fund is committed to advancing research and developing innovative treatments using psychedelics to address conditions like depression, anxiety, PTSD, and other mental health issues. Mystic Ventures typically invests in pre-seed and seed-stage companies that are pioneering these therapies. Led by Jeremy Gardner and Brock Pierce, the firm takes a biotech-oriented approach, partnering with scientific research teams and pharmaceutical experts to bring cost-effective, holistic psychedelic solutions to the mainstream. With a rolling fund structure on AngelList, Mystic Ventures is uniquely positioned to offer flexible capital to startups, supporting their long-term growth in the burgeoning field of psychedelic therapeutics. The fund has backed companies like Psylo and Heading Health, among others. By investing in breakthrough treatments that go beyond traditional pharmaceutical approaches, Mystic Ventures aims to reshape how mental health treatments are developed and accessed, while offering investors exposure to this transformative market.

N49P Ventures, established in 2019 and headquartered in Toronto, Canada, focuses on seed-stage investments in Canadian technology startups. The firm primarily invests in sectors such as e-commerce, AI, fintech, and software, supporting companies with their growth and market expansion strategies. Notable portfolio companies include Visualping, which raised $6 million for its website change monitoring service, and Rally, a software company that secured $10 million in funding. N49P has also backed startups like Spellbook and EvenUp, both of which operate in the legal AI space​. The team at N49P includes founders Doug Penick, Alex Norman, and Omar Dhalla, all of whom bring extensive experience in investment and operational roles. They are actively involved in supporting their portfolio companies through fundraising, customer introductions, and ongoing coaching. N49P emphasizes building a strong community of investors who are dedicated to supporting the Canadian tech ecosystem. This community includes active founders, business executives, and exited teams who contribute their expertise and networks to help portfolio companies succeed​.

Nama Ventures is a seed-stage venture capital fund based in Riyadh, Saudi Arabia, focused on fueling innovation across the MENA region, particularly in Saudi Arabia. Founded by Mohammed Alzubi, the fund is committed to nurturing early-stage technology startups with a strong emphasis on team-based ventures over solo founders. Their portfolio includes notable investments like PIESHIP in logistics, palm.hr in business productivity software, and Brev.dev, an AI and ML platform recently acquired by NVIDIA. Nama Ventures emphasizes supporting startups from pre-seed to seed stages, often leading funding rounds and providing strategic guidance to help ventures grow and realize their potential. They have invested in 47 companies, achieving several successful exits, including the acquisition of Brev.dev by NVIDIA. The fund recently launched a $27 million fund to further invest in MENA startups, with some allocations for Silicon Valley-based ventures through strategic syndication partners. Nama Ventures' investment strategy is centered around fostering technology innovation and supporting startups with complementary skill sets in their founding teams. For startups looking to approach Nama Ventures, it's crucial to demonstrate a robust team dynamic, innovative technology, and the potential for significant impact and growth within the targeted markets. The leadership team, including Mohammed Alzubi, brings extensive experience from Silicon Valley, offering a wealth of knowledge and a strong network to support portfolio companies in achieving their goals and scaling their businesses effectively.

Natural Bridges Ventures (NBV) is a global venture capital firm based in Silicon Valley, specializing in scaling disruptive technologies through a unique blend of strategic guidance and operational acceleration. NBV focuses on early-stage companies that operate at the intersection of communication, collaboration, and technological innovation. With an emphasis on design thinking, the firm partners with startups aiming to transform markets in areas such as IoT, digital health, mobility, and the digital enterprise​. What sets NBV apart is its global network and ability to connect startups with ecosystems across key regions, including the U.S., Europe, Asia, Israel, and Latin America. The firm employs a disciplined, process-oriented approach to ensure rapid market entry and scaling for its portfolio companies. NBV works closely with corporate partners and startups alike, facilitating the integration of external innovation into larger business ecosystems. Their focus on "innovation by design" helps identify untapped opportunities and empower businesses to create lasting, market-shifting solutions​. NBV's portfolio includes high-growth ventures that leverage cutting-edge technologies to address critical challenges across multiple sectors. By nurturing startups with both strategic investment and hands-on operational support, NBV accelerates their journey from concept to commercialization. With a cross-functional team of experienced entrepreneurs and corporate executives, the firm offers both financial and strategic resources, ensuring that their portfolio companies can navigate complex markets and achieve sustained growth on a global scale.

Nauta Capital is a leading pan-European venture capital firm, specializing in early-stage B2B software startups. Founded in 2004, Nauta operates from offices in London, Barcelona, and Berlin, with over €550 million in assets under management. Their investment strategy is focused on supporting companies that leverage innovative technologies to transform traditional industries, particularly in sectors such as SaaS, fintech, insurtech, health tech, AI/ML, and deep tech. Nauta's typical investment size ranges from €1 million to €5 million, and they actively participate from late seed to Series B stages. The firm’s hands-on approach is evident in their deep involvement with portfolio companies, offering strategic guidance and operational expertise to help founders scale their businesses across international markets. With over 180 investments to date, Nauta has established a strong track record, having supported high-growth startups like Brandwatch, MishiPay, Cledara, and Holded, the latter two of which have been instrumental in revolutionizing SaaS management and retail technology​. Nauta’s impressive exit portfolio includes major successes such as the $450 million acquisition of Brandwatch by Cision, and the acquisition of Holded by Visma. Nauta continues to expand its reach, recently closing a €190 million fund aimed at boosting investments in more than 35 companies. They are also pushing into deep tech through Nauta Labs, an initiative designed to seed early-stage innovation​. Through their collaborative, long-term focus, Nauta Capital remains committed to fostering visionary founders and helping them navigate the complex journey from startup to scale-up.

Navigare Ventures, founded in 2021 and based in Stockholm, is an early-stage venture capital firm specializing in science-driven companies. As a subsidiary of Wallenberg Investments AB, Navigare Ventures focuses on deep tech sectors, including advanced computing, quantum technologies, synthetic biology, bio innovation, and data-driven life sciences. The firm is committed to investing in transformative technologies that have a strong industrial and societal impact. Navigare Ventures typically invests in Seed and Series A rounds, partnering closely with founders to support the growth and development of their companies. The firm has a robust portfolio that includes companies like Elypta, a startup developing metabolism-based liquid biopsy technology for cancer detection, and EnginZyme, which focuses on sustainable biomanufacturing. Their investment strategy is characterized by long-term partnerships, leveraging an extensive network of scientific and industrial expertise to help startups scale and succeed in their respective fields​.

Navy Capital is a New York-based hedge fund founded in 2014, with a strong focus on the rapidly expanding global cannabis industry. The fund operates through a research-driven, long/short equity strategy, leveraging deep analysis to identify undervalued opportunities primarily within the legal cannabis, cannabis healthtech, and crop tech sectors. Their investment portfolio includes notable startups like Sanity Group, Harborside, and C3 Industries, making Navy Capital a significant player in the cannabis and consumer non-durables spaces. Geographically, Navy Capital concentrates investments predominantly in the U.S., while also backing ventures in Germany and other regions. The fund's average check size typically targets early to mid-stage companies, often participating in Series A and B rounds. However, they remain flexible in their approach, willing to lead or co-invest alongside other firms depending on the opportunity. The team is led by Sean Stiefel, CEO and Founder, and supported by key players like Chetan Gulati, Head of Research. With a background in hedge fund management and macro strategy, the team boasts a combined experience across finance, law, and global equity markets. Navy Capital's proactive approach to investing, combined with a willingness to engage deeply with portfolio companies, helps build strong relationships with founders. Startups looking to connect are encouraged to demonstrate solid fundamentals and long-term growth potential, particularly in regulated industries like cannabis, where Navy Capital thrives.

Naxicap Partners, a subsidiary of Natixis Private Equity, is a leading French private equity firm managing €6.7 billion in assets as of the end of 2022. The firm focuses on mid-cap buyouts and small-cap growth investments across diverse sectors including healthcare, technology, real estate, and business services. They are known for supporting companies with strong growth potential and stable business models, adapting their investment focus based on sectoral economic dynamics. Notable investments in Naxicap's portfolio include Advanced Accelerator Applications, a developer of molecular nuclear medicine theragnostics, and Alltub, a manufacturer of collapsible aluminum tubes. The firm has also seen successful exits such as the sale of Maxi Bazar to the Zouari family group and House of HR to Bain Capital. Naxicap has a strong commitment to ESG principles, having received the highest rating from the UN Principles for Responsible Investment for Strategy & Governance. They focus on incorporating ESG issues into their investment analyses and ownership policies, promoting sustainability within the investment industry.

NCL Technology Ventures is a UK-based venture capital firm specializing in early-stage investments across the healthcare and life sciences sectors. Founded in 2010, the firm focuses on identifying and backing companies that are driving transformational change in healthcare, with a particular emphasis on innovation in areas such as therapeutics, medical technologies, and digital health. NCL's mission is to foster companies that are developing breakthrough solutions to address global health challenges, from preventive care to cutting-edge treatments​. The firm's investments typically range between €1.5M and €3M, with a strong focus on seed and Series A funding. NCL is deeply involved in the strategic development of its portfolio companies, providing both capital and operational expertise to help them navigate the complexities of the healthcare landscape. The firm's portfolio includes companies like TC BioPharm, which is pioneering allogeneic cell therapies, and Curesponse, a precision medicine startup. With offices in London and the US, NCL is well-positioned to support its portfolio globally, fostering partnerships and driving innovation in both European and American markets. Their team, led by experienced venture capitalists like Jerry Biggs and Jonathan Synett, brings decades of investment and entrepreneurial expertise to the table.

Necessary Ventures is a San Francisco-based venture capital firm focused on investing in early-stage companies that address significant societal needs. The firm is led by Neil Devani, who brings extensive experience in both venture capital and entrepreneurship. Necessary Ventures primarily invests in companies across a range of sectors including health tech, financial services, biotechnology, and sustainability. Notable investments in their portfolio include Recursion Pharmaceuticals, a company revolutionizing drug discovery through advanced computational methods; Rubi Laboratories, which converts CO2 into sustainable textiles; and Andela, a tech talent training and employment platform. Additionally, they have backed Vicarious Surgical, which develops minimally invasive robotic surgery technology, and Wayve, an AI-driven autonomous vehicle company. The firm is known for its hands-on approach, providing not just capital but also strategic guidance and support to help their portfolio companies scale and succeed. They emphasize a collaborative and empathetic partnership with founders, aiming to create long-term value and impact. Necessary Ventures has a strong presence in both the U.S. and international markets, with investments in various high-growth regions. They have co-invested with leading venture funds such as Y Combinator, Collaborative Fund, and Talis Capital, highlighting their integration into a robust network of investors.

Neo is a venture capital firm based in San Francisco, founded by Ali Partovi, with a strong emphasis on supporting the next generation of tech leaders. Launched in 2012, Neo invests primarily in early-stage startups, often serving as the first institutional investor for many high-growth companies. Neo focuses on industries like AI, consumer internet, and education, investing in startups that have the potential to drive significant innovation. Neo’s investment strategy is centered on a hands-on approach, offering both financial backing and access to a powerful network of industry leaders. With check sizes ranging from $100K to $5 million, Neo supports startups from seed through Series A stages. They also place a high value on mentorship, connecting founders with an elite community of experienced entrepreneurs, engineers, and executives who offer guidance throughout the startup journey. The firm's portfolio includes some of the most promising startups in the tech space, such as Gusto, Pachama, and Notion. Neo prides itself on fostering diversity and inclusion, believing that the best tech companies are built by teams from a variety of backgrounds. Led by Ali Partovi and supported by a team of seasoned investors and operators, Neo is committed to making a long-term impact in the startup ecosystem by focusing on companies that combine technological innovation with meaningful social impact.

Neo Kuma Ventures, established in 2020 and headquartered in London, is Europe’s largest VC fund focused exclusively on psychedelic healthcare. Neo Kuma aims to revolutionize the treatment of mental health conditions such as depression, PTSD, addiction, and chronic pain through investments in cutting-edge psychedelic therapies. They invest in early-stage companies (Pre-Seed to Series A), deploying capital in the range of £150k to £1 million, with a particular focus on clinical research and digital therapeutics. Neo Kuma's portfolio includes significant players in the field, such as ATAI Life Sciences, Beckley Psytech, and Small Pharma, companies that are advancing the frontiers of mind-altering medicines and therapeutic platforms. Neo Kuma’s strategy is hands-on, working closely with founders to navigate both scientific development and regulatory challenges in this emerging market. The firm is led by a team of experienced investors like Clara Burtenshaw and Sean McLintock, both of whom bring a wealth of expertise in biotech, venture capital, and finance. Neo Kuma is not only a financial backer but also a policy influencer, collaborating with leading organizations in psychedelic research, such as the International Therapeutic Psilocybin Rescheduling Initiative. This integrated approach positions Neo Kuma as a key player in reshaping the future of mental healthcare through psychedelics.

Neotribe Ventures, founded in 2017 and based in Menlo Park, California, is a venture capital firm that focuses on investing in breakthrough technologies across various sectors including applied artificial intelligence, biotech, enterprise infrastructure, and the internet of things. The firm targets early to growth-stage companies that are shaping the future through innovative solutions. Neotribe Ventures has made 98 investments with notable companies in its portfolio such as Energy Vault, Heliogen, and CipherTrace. The firm has achieved 17 exits, including significant companies like Robinhood, which went public in July 2021. Other successful exits include Pluribus Networks and ClearMotion. The firm is led by co-founders Swaroop Kolluri and Steven Bragonier, along with partners like Nitin Chopra and Neeraj Hablani. Neotribe Ventures manages nearly $450 million in assets across three funds, including the recent Ignite Fund, which focuses on growth-stage investments. Neotribe Ventures' strategy involves providing not just capital but also extensive support and resources to help their portfolio companies succeed. The firm's emphasis on deep technology and innovative solutions makes it a significant player in the venture capital landscape​.

Nesta Impact Investments, the venture capital arm of Nesta, focuses on funding innovative tech ventures that aim to create significant social and environmental impact. The firm, rebranded from Janvest Capital Partners, operates with a clear mission to make the world healthier, fairer, and more sustainable by 2030. Their recent £50 million fund targets startups in sectors like edtech, foodtech, healthtech, climate tech, and the future of work. Nesta's portfolio includes companies such as Bibliu, an educational resource platform; Skin Analytics, an AI tool for skin cancer detection; and Arbor Education, a data and software provider for schools. They have also supported Koru Kids, a tech-enabled childcare platform; Habitual Health, a program for reversing Type 2 diabetes; and Oxford Medical Products, which developed a "gastric balloon in a pill". Nesta's approach involves more than just providing capital. They offer comprehensive support through their vast network, policy knowledge, and expertise in data and behavioral insights, ensuring portfolio companies can scale while maintaining their mission-driven focus. Investments typically range from £500k to £1m for Seed to Series A rounds, with potential follow-up investments of up to £4 million.

Neulogy Ventures, established in 2014 and based in Bratislava, Slovakia, is a Luxembourg-regulated venture capital fund. The firm focuses on early-stage tech companies, particularly those operating in Slovakia and the Central and Eastern Europe (CEE) region. Neulogy Ventures manages €65 million in assets, with a diverse portfolio spread across 10 countries. The fund targets investments in sectors like media, cleantech, data analytics, productivity applications, medtech, infrastructure, fintech, security, 3D, e-commerce, and new energy. Neulogy Ventures aims to support mission-driven entrepreneurs with bold ideas that push technological frontiers, particularly those addressing climate change and healthcare challenges. Neulogy Ventures emphasizes a hands-on approach, offering strategic guidance, business development support, and fundraising assistance to its portfolio companies. The firm values long-term partnerships, prioritizing shared values and a collaborative approach over quick exits. Notable companies in Neulogy's portfolio include GA Drilling, GreenWay, and GroupSolver. The team, led by managing partners Christian Mandl and Jaroslav Luptak, brings extensive experience in entrepreneurship, fundraising, and business development, ensuring robust support for their investees.

Neva SGR, founded in 2020, is the venture capital arm of Intesa Sanpaolo Group, one of Italy's largest banking institutions. Based in Turin, Neva focuses on investing in technology-driven companies at various stages, from seed to Series C. The firm is sector-agnostic but leans heavily towards fintech, deeptech, ESG transition technologies, and core tech innovations. With two main funds—Neva First and Neva First Italia—the firm targets both Italian and international startups. Neva First focuses on global opportunities, with a minimum of 30% invested in Italian companies, while Neva First Italia co-invests with a more localized emphasis on Italian startups. The funds have a combined budget of around €500 million, with an average ticket size of €4-10 million per investment. Neva SGR is particularly active in life sciences and deeptech, with notable portfolio companies including D-Orbit in space logistics and Tr1X, a biotech firm focused on autoimmune therapies. The firm’s mission is to foster innovation that addresses global challenges while boosting the Italian and European tech ecosystems.

NevCaut Ventures is a dynamic venture capital firm established in 2021 and headquartered in Irvine, California. Focused primarily on FinTech, NevCaut invests in pre-seed, seed, and Series A companies that are pushing the boundaries of financial technology to foster inclusivity and innovation. The firm prides itself on its ability to provide more than just capital, leveraging deep regulatory expertise and extensive networks in financial services to help startups navigate complex regulatory landscapes and scale effectively. With a portfolio that includes prominent companies like Upgrade, FairPlay, and Synctera, NevCaut Ventures targets businesses that offer solutions in financial services, business productivity software, and compliance management. The firm’s average investment ranges from seed rounds to early Series A funding, with several of its portfolio companies advancing to unicorn or "soonicorn" status. The leadership team, led by co-founders Dan Quan and Erik Brue, brings a wealth of experience from both the public and private sectors. Dan Quan, a former senior advisor at the U.S. Consumer Financial Protection Bureau (CFPB), played a significant role in driving fintech innovation and regulatory adaptation in the U.S. Meanwhile, Erik Brue offers deep expertise in data and technology, stemming from his extensive experience in company management and founding ventures. NevCaut's mission is to support ambitious founders who are creating impactful financial solutions for a more inclusive world, making it a key player in the rapidly evolving fintech landscape.

New Age Capital, founded in 2016 by Ivan Alo and LaDante McMillon, is a New York-based venture capital firm focusing on seed-stage investments in tech and tech-enabled startups led by Black and Latino entrepreneurs. The firm aims to bridge the funding gap for underrepresented founders by providing not only capital but also strategic guidance and access to a robust network of investors and partners. The firm typically invests between $850,000 and $1 million per company, targeting an ownership stake of 10-15%. New Age Capital prefers to lead funding rounds and maintains a hands-on approach, fostering long-term relationships with founders well in advance of their capital needs. This strategy allows the firm to provide tangible value and support through various growth stages. New Age Capital's portfolio includes a diverse array of companies such as Myavana, a personalized hair care recommendation platform; PredictionStrike, a sports stock market; and Navigate Maternity, which uses data to support prenatal and postpartum care. The firm's emphasis on authenticity, empathy, and transparency has positioned it as a trusted partner for founders from historically underfunded communities. By focusing on capital-efficient, high-potential startups in large and fragmented markets, New Age Capital aims to generate outsized returns while driving significant impact in the entrepreneurial ecosystem.

New Enterprise Associates (NEA) is a global venture capital firm with a storied history of supporting innovative businesses. Founded in 1977, NEA manages over $25 billion in assets and invests across all stages of a company's lifecycle, from seed stage to IPO. The firm has a diverse portfolio that spans technology and healthcare sectors. NEA's notable investments include companies like 23andMe, Coursera, Robinhood, and Uber, highlighting their focus on transformational businesses. They have facilitated over 270 IPOs and more than 450 mergers and acquisitions, underscoring their impact on the market. The firm operates from key locations in Menlo Park, California, and New York City, but their investment reach is global, covering North America, Europe, Asia, and beyond. NEA's strategy involves not just funding but also actively mentoring and supporting their portfolio companies through various stages of growth. Recently, NEA closed on two new funds totaling $6.2 billion, the largest in the firm's history, aimed at early-stage and growth-stage investments in sectors like enterprise tech, fintech, digital health, and life sciences. This reflects NEA’s commitment to driving innovation and supporting founders with the capital and expertise needed to build successful companies.

NLV Partners, founded in 2005, is a leading venture capital firm focused on revolutionizing healthcare. With notable investments in companies like CRISPR Therapeutics, Akili Interactive Labs, and iRhythm Technologies, NLV Partners targets biopharmaceuticals, diagnostics, medical devices, and healthcare IT. Their portfolio boasts 30 billion-dollar companies and numerous successful exits, reflecting their impact in the industry. Geographically, NLV Partners concentrates on the United States, partnering with businesses from startup stages to public offerings. Their investment strategy involves backing visionary teams and disruptive healthcare technologies. They aim to develop commercially attractive and clinically important healthcare solutions, leveraging decades of experience and deep domain expertise to navigate the complex healthcare landscape. NLV Partners typically leads investment rounds, providing not only capital but also strategic guidance. They prefer to be approached through well-prepared pitches that clearly demonstrate the potential for clinical and commercial success. The fund's average check size varies, tailored to the needs of each investment. The team includes co-founders Ron Hunt and Vijay Lathi, based in New York and Menlo Park respectively. Both bring extensive experience in healthcare investments and have been instrumental in shaping the firm's strategic direction. For startups seeking a partner with profound industry knowledge and a track record of success, NLV Partners stands out as a pivotal ally in the healthcare sector.

New Markets Venture Partners is a leading venture capital firm focused on education and workforce technology. They have invested in notable companies such as App Academy, Credly, and Galvanize, which provide innovative solutions to enhance education and career development. The firm emphasizes investments in companies that bridge gaps in education and the labor market, particularly those that impact at-risk populations in the U.S. Their primary investment areas include 21st-century skills, workforce preparation, alternative educational pathways, and the future of work. They seek growth-stage companies that have demonstrated product-market fit and scalable business models with high gross margins. New Markets typically invests at the Series A stage and beyond, with an average investment size ranging from $1M to $5M. Based in Fulton, Maryland, New Markets operates across the United States, focusing on impact-driven, evidence-based solutions. The team, led by co-founders Mark Grovic and Jason Palmer, brings decades of experience in institutional investing, with a strong network of strategic partners including foundations, non-profits, and corporations. New Markets Venture Partners prides itself on its mission-driven approach, supporting entrepreneurs through strategic guidance, operational advice, and introductions to a vast network of industry leaders and potential partners. They are particularly interested in companies that demonstrate efficacy in their solutions and have a clear path to significant social impact​.

New Money Ventures is a venture capital firm dedicated to transforming the future of consumer goods and wellness by investing in purpose-driven brands. Led by CEO and founder Jaclyn Johnson, the firm focuses on early-stage startups that are redefining their respective industries through innovation and impact. New Money Ventures primarily targets companies in the beauty, health, wellness, and consumer tech sectors. With a mission to empower underrepresented founders, particularly female and diverse entrepreneurs, the firm actively looks for startups that emphasize sustainability, inclusivity, and social impact. Their investment strategy is not just financial; they offer mentorship, strategic guidance, and access to a broad network of resources to help founders scale their businesses effectively. The firm has invested in brands like OUAI Haircare, Doe Lashes, and INBLOOM, reflecting its commitment to backing companies that prioritize both purpose and profit. New Money Ventures also stands out for its focus on creating long-term partnerships with founders, ensuring that the startups they support have the resources and guidance necessary to thrive in highly competitive markets.

VisVires New Protein, recently rebranded as Clay Capital, is a Singapore-based venture capital firm dedicated to transformative investments in the agrifood tech sector. Founded in 2014, Clay Capital focuses on supporting innovative startups that address fundamental challenges in the food system, particularly in the areas of sustainable packaging, fermentation, agricultural biologicals, crop disease resistance, soil health, and regenerative agriculture. Notable investments include French biostimulant producer Toopi, Israeli bioherbicide startup WeedOUT, and French kitchen robot manufacturer Cook-e. These investments reflect Clay Capital's commitment to leveraging technology to improve sustainability and efficiency in the food and agriculture sectors. Clay Capital's strategy involves investing in early-stage to growth-stage startups, typically with initial checks ranging from $3 million to $8 million, and reserving additional capital for follow-on investments. The firm serves as a bridge between the Asian and European markets, providing startups with support to access and expand in these regions. The rebranding from VisVires New Protein to Clay Capital signifies a renewed focus on building a healthy and sustainable food system, symbolizing fertile ground for growth and innovation. With a newly raised $145 million fund, Clay Capital is well-positioned to continue driving impactful changes in the agrifood tech landscape

New Science Ventures (NSV) is a premier venture capital firm established in 2004, with offices in New York and London. The firm specializes in investing in companies that leverage groundbreaking scientific innovations in the life sciences and information technology sectors. NSV has a keen focus on businesses with strong IP protection and those addressing significant unmet market needs. Notable investments include Ventyx Biosciences, Phase Four, Achronix Semiconductor, and Paragraf. NSV is particularly interested in companies that can transform their industries with innovative scientific approaches. Their strategy is to invest in both early and mid-stage companies, supporting them through crucial growth phases to maximize their potential and value. NSV is not afraid to take contrarian views and often seeks opportunities outside traditional tech hubs, emphasizing the importance of science-based innovation. The firm typically leads funding rounds and provides substantial follow-on support, ensuring that their portfolio companies have the resources needed to succeed. Key team members include co-founder Tom Lavin, who brings over 30 years of experience in finance and investment banking, and Raju Mohan, a seasoned biotech entrepreneur and senior advisor with extensive expertise in drug discovery and development. Startups looking to engage with NSV should emphasize their scientific uniqueness and potential for significant market impact. NSV values strong management teams and clear, defensible IP strategies, making these essential points of focus when approaching the firm.

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Stack Ventures is an early-stage venture capital firm focused on investing in founders who are often overlooked by traditional venture capital firms. Founded by Nick Moran, New Stack Ventures targets startups in under-capitalized markets and geographies, with a particular focus on IoT, deep tech, smart hardware, and various platform-based business models. The firm recently closed its second fund, New Stack Ventures Fund II, at $42.6 million, significantly larger than its first $6 million fund. This new fund allows New Stack to support an additional 35 companies at the pre-seed and seed stages. The firm prides itself on being one of the largest single-partner funds raised outside of the typical Silicon Valley ecosystem, emphasizing its commitment to backing "outsider" founders. New Stack Ventures has built a strong reputation for its proactive and founder-friendly approach. The firm was highlighted by TechCrunch as one of the most active and engaged investors in the industry. Its portfolio includes notable companies like Draftbit, Curv, and Flamingo, reflecting its diverse investment strategy. The team at New Stack Ventures is comprised of experienced professionals, including Nate Pierotti, Luke Skertich, and Ariella Frank, who bring extensive backgrounds in startups, product management, and venture capital. Their collaborative and inclusive investment process ensures they identify and support high-potential startups effectively.

New Wave Ventures is a dynamic, privately-owned venture capital fund based in London. Focused on investing in companies with significant growth potential, New Wave targets initial investments ranging from £500,000 to £2,000,000. Unlike many funds, New Wave Ventures invests its own capital without relying on external investors, allowing for a more flexible and long-term investment approach. Their investment philosophy centers on the belief that great businesses are built by great people. New Wave Ventures seeks entrepreneurs who can overcome obstacles and dominate their markets on a global scale. They prefer to co-invest with like-minded partners but often opt to be the sole investor alongside committed owner-managers. This fund is not driven by short-term exits or leverage; instead, it focuses on sustainable growth and strategic support​. Geographically, New Wave Ventures concentrates on the UK, particularly the North West region, encompassing cities like Manchester and Liverpool. Their goal is to fill the funding gap for early-stage and scale-up businesses in these areas, fostering innovation and growth​. The leadership team at New Wave brings a wealth of experience in running successful businesses and tackling various challenges. Their approach involves minimal interference in day-to-day operations, instead offering strategic guidance and financial support. Startups can reach out directly via email for potential investment opportunities​. This combination of substantial financial backing, strategic expertise, and a people-first philosophy makes New Wave Ventures a compelling partner for ambitious entrepreneurs looking to scale their businesses.

New York Angels, founded in 2004, is one of the most active and well-established angel investor groups based in New York City. Specializing in early-stage investments, the group has made over 386 investments, with notable successes including Greenhouse Software, Payoneer, and Billtrust. Their portfolio spans various sectors such as Artificial Intelligence, Fintech, Healthcare, and SaaS. New York Angels typically invests in increments starting from $25,000 and expects its members to invest a minimum of $50,000 annually in its deals. Their average investment round size is around $2 million, and they are known for both leading and participating in follow-on rounds. The group has achieved 72 exits, indicating a strong track record of identifying and nurturing high-potential startups. The investment strategy of New York Angels emphasizes thorough due diligence and a collaborative approach, leveraging the diverse expertise of its members. They actively engage with their portfolio companies, providing not only capital but also valuable mentorship and networking opportunities. Key figures in the organization include founder David S. Rose, who has played a pivotal role in shaping the group's investment philosophy and operations. Startups looking to secure funding from New York Angels should be prepared to demonstrate strong business fundamentals and a clear growth trajectory

New York Venture Partners, founded in 2014, is a venture capital firm based in New York City. NYVP focuses on early-stage investments, particularly in seed rounds, and aims to support startups with both capital and strategic guidance. The firm has a diverse portfolio with investments across various industries, including enterprise software, cybersecurity, AI, fintech, and health tech. NYVP is known for its notable investments in companies like VHX, Food52, and CrowdTwist, which have achieved significant market success. The firm typically invests check sizes ranging from $300,000 to $700,000, allowing it to support startups through critical early development phases. NYVP's investment strategy emphasizes partnering with innovative entrepreneurs and providing them with resources beyond just financial support. This includes access to experienced advisors who can offer strategic guidance, as well as operational support to help with recruiting and fundraising efforts.

Empire State Development (ESD) is New York State's chief economic development agency, focusing on promoting business growth, job creation, and enhancing the state’s overall economy. Through various programs and initiatives, ESD supports businesses of all sizes and industries, providing financial incentives, grants, loans, and other resources to foster economic development across the state. One of ESD's flagship programs is the "FAST NY" initiative, which aims to create shovel-ready sites for industrial development, providing substantial grants to improve infrastructure like transportation, utilities, and site development. This program has committed over $175 million to support over 2,700 acres of industrial property. ESD is also a major player in fostering innovation through investments in life sciences and biotech. For instance, the expansion of Harlem Biospace, supported by a $1.5 million ESD grant, exemplifies its role in nurturing New York’s biotech ecosystem by providing advanced facilities for startups and fostering collaboration between businesses and academic institutions like Columbia University. Overall, ESD’s initiatives are focused on strategic job creation, attracting innovative industries, and revitalizing communities, helping to position New York as a competitive environment for both startups and established businesses.

Newark Venture Partners is a seed-stage venture capital firm based in Newark, New Jersey, with a strong focus on B2B software companies. Founded in 2015, NVP aims to support innovative startups by providing seed funding and operational support to foster growth and success. The firm has raised approximately $90 million for its second fund, doubling the size of its first fund. NVP's investment strategy revolves around healthcare, fintech, and supply chain sectors, seeking startups that offer transformative solutions in these high-stakes industries. The firm’s portfolio includes notable companies like Podsights, Optimal Dynamics, and Handspring Health, highlighting their commitment to driving innovation in enterprise software. The team at NVP is led by Managing Partners Tom Wisniewski, Dan Borok, and Vaughn Crowe, who bring extensive experience in venture capital and entrepreneurship. The firm is known for its active involvement in the Newark community, including partnerships with organizations like the Boys and Girls Club of Newark and Braven, which support local talent and promote educational and employment opportunities.

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.